848841-48-5 Usage
Uses
Used in Pharmaceutical Research and Development:
1-Chloro-4-isoquinolinyl boronic acid is used as a key building block for the synthesis of various pharmaceuticals and agrochemicals. Its ability to form stable and selective bonds with other molecules, especially diols and catechols, makes it instrumental in the development of new drugs and chemical compounds.
Used in Organic Synthesis:
In the field of organic synthesis, 1-Chloro-4-isoquinolinyl boronic acid is utilized as a versatile reagent, particularly in Suzuki-Miyaura cross-coupling reactions. These reactions are crucial for constructing carbon-carbon bonds in the synthesis of complex organic compounds, highlighting the compound's importance in advancing chemical synthesis techniques.
Used in Medicinal Chemistry:
1-Chloro-4-isoquinolinyl boronic acid plays a significant role in medicinal chemistry due to its unique chemical properties. Its reactivity and capacity to form selective bonds contribute to the discovery and design of novel therapeutic agents, thereby enhancing the scope of treatment options for various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 848841-48-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,8,8,4 and 1 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 848841-48:
(8*8)+(7*4)+(6*8)+(5*8)+(4*4)+(3*1)+(2*4)+(1*8)=215
215 % 10 = 5
So 848841-48-5 is a valid CAS Registry Number.
848841-48-5Relevant academic research and scientific papers
1,4-DISUBSTITUTED ISOQUINILONE DERIVATIVES AS RAF-KINASE INHIBITORS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES
-
Page/Page column 51, (2010/02/11)
This invention relates to compounds of formula (I) wherein the variable substituents are described herein. The compounds are useful for the treatment of conditions and diseases characterized by an aberrant MAP kinase signaling pathway, such as cancer.
